GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biohit Oyj BIOBV.HE ยท EUR

Health Care ยท Nasdaq Helsinki ยท ๐Ÿ‡ซ๐Ÿ‡ฎ Finland

Compare

2.13

-2.29%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biohit Oyj โ€” daily BIOBV

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Biohit Oyj on TradingView โ†—
Market value
โ‚ฌ26.0m
Last close ร— shares
Volume
8.1k
Shares, 9 Nov 2026
Price to earnings
10.0

About Biohit Oyj

Its shares trade on Nasdaq Helsinki under the ticker BIOBV.HE. It has been listed since 18 June 1999. In the fiscal year to 31 December 2025, it reported revenue of โ‚ฌ15.7m and net income of โ‚ฌ2.7m. At that date it held total assets of โ‚ฌ19.8m and shareholders' equity of โ‚ฌ14.9m.

Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. The company is headquartered in Helsinki, Etela-Suomen. The firm operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. The company provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Companyโ€™s products are used in hospitals, healthcare centers and research institutions. The company operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Biohit Oyj โ†’

Latest on Biohit Oyj

Our reporting

We have not reported on Biohit Oyj yet.

Next results

17 Feb 2027

Due on 17 Feb 2027. Analysts expect earnings of 0.08 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

โ€”

Return

โ€”

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biohit Oyj's ticker?

Biohit Oyj trades as BIOBV.HE on Nasdaq Helsinki, under ISIN FI0009005482.

What was Biohit Oyj's last closing price?

2.13 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Biohit Oyj next report results?

Results are expected on 17 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.